Ondine Biomedical Inc (AIM:OBI) (Ondine Biomedical Inc (AIM:OBI)) is a Canadian headquartered, medical device company led by founder and CEO, Carolyn Cross. The company has developed a patented, painless, photodisinfection technology platform used in treatment and prevention therapies for a broad-spectrum of pathogens - including multidrug-resistant strains. Photodisinfection is a targeted antimicrobial which uses non-thermal light to activate a photosensitive agent. In a few minutes, this light-based therapy destroys the pathogens' cell membranes and surface proteins through an oxidative burst without any impact on human tissue.
Ondine Biomedical Inc (LON:OBI) Elevator Pitch
